AI Signal & Stock Analysis · Very Strong ↑
As of Sep 28 2026, 6:09 PM, AkshayaAI's signal for LLY is Very Strong ↑; the stock is at $1,184.78 (+0.11% today); neutral (RSI 56); technical trend is Raise; news sentiment is negative.
Data as of Sep 28 2026, 6:09 PM. Informational analytics only — not investment advice.
| AI signal (Strength) | Very Strong ↑ |
|---|---|
| Price | $1,184.78 |
| Change today | +0.11% |
| RSI (14) | 56.04 |
| Relative volume | 0.74 |
| Composite (RMTPGV) score | 🔒 members |
| Market cap | $1.12T |
| Forward P/E | 25.27 |
| 52-week high | -8.3% away |
| 52-week low | +65.5% above |
| Technical trend | RAISE-2026-09-24 |
| News sentiment | Negative |
| Sector | Healthcare-Genetherapy |
| Next earnings | 8/5/2026 8:30:00 AM |
As of Sep 28 2026, 6:09 PM, AkshayaAI assigns LLY (Lilly(Eli) & Co) a Very Strong signal. The composite (RMTPGV) score and full factor breakdown are available to signed-in members.
LLY's RSI is neutral (RSI 56). A reading above 70 is typically considered overbought and below 30 oversold.
LLY is trading about 8% below its 52-week high and 65% above its 52-week low as of Sep 28 2026, 6:09 PM.
LLY's next earnings date is 8/5/2026 8:30:00 AM.
LLY is classified under Healthcare-Genetherapy in AkshayaAI's taxonomy.
AkshayaAI refreshes its signals daily. The figures on this page are timestamped as of the latest run shown above.
No. AkshayaAI provides informational, AI-generated analytics for LLY — not personalised investment advice. Always do your own research.
AZN · NVO · ILMN · BBIO · HALO · CORT
AkshayaAI provides AI-generated, informational stock analytics for US and India markets. This is not personalized investment advice. Figures are as of Sep 28 2026, 6:09 PM and may not reflect real-time prices. Always do your own research. How these signals work →
Instant, data-backed answers — free to try.